Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Sarepta Therapeutics, Inc.”

102 pharma patents match "Sarepta Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 5 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "Sarepta Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “Sarepta Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 8697858

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  2. US 8618270

    Oligonucleotide analog and method for treating flavivirus infections

    Sarepta Therapeutics, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  3. US 8592386

    Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

    Sarepta Therapeutics, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  4. US 8536147

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  5. US 8524676

    Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

    Sarepta Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  6. US 8501704

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.